Vaxxas has received a manufacturing licence from Australia’s Therapeutic Goods Administration (TGA) for its high-density ...
Microarray technology encompasses a few relatively well-established methods and numerous applications that are in various stages of development. Apart from their use as a tool for diagnostic testing ...
Vaxxas Chair Sarah Meibusch said, “The TGA manufacturing licence marks a significant milestone for Vaxxas as we progress toward commercialising our HD-MAP technology. By reducing cold-chain ...
The Global Gene Expression Market is estimated to be valued at USD 16.56 Bn in 2025 and is expected to reach USD 23.61 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2025 to ...
With an estimated more than 10 million cases, India accounts for nearly 20% of the global epilepsy burden. The number of ...
Some of our most promising biotechs have taken part in a pre yuletide rush of clinical trial updates – and there is much to ...
Whole Genome Amplification (WGA) offers vast opportunities in personalized medicine, cancer research, and reproductive health ...
With over a decade of experience architecting and operating large-scale cloud environments across AWS, Azure, and Google ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback